For a broader comparison, see our semaglutide vs tirzepatide page
Higher-potency formulations (semaglutide up to 2.4 mg and tirzepatide) were used, which may account for stronger weight effects compared to pediatric trials that employed lower doses
In female patients, menstrual problems and issues with repeated miscarriage have been reported[11]
Gastrointestinal Distress: Acute systemic loads exceeding 10 mg frequently trigger nausea, severe cramping, and gastrointestinal rejection
This remains an emerging application and should be discussed carefully with your provider, but for patients who have plateaued with conventional rehabilitation, Synapse may offer an additional pathway
Those dealing with pigmentation, dullness, or aging skin